Janux Therapeutics, Inc. - JANX

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 4/4/2025 10:40:59 PM
EDGAR CIK 0001817713

Buy Breakdown

Total $0

Sell Breakdown

Total $7,459,389

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
01/07/2025
10b5-1
01/08/2025
Campbell David Alan
President and CEO
CEO Director
Sell
-5,000 @ $60.00
($300,004.00)
 293,054 (-1.68%) Direct
01/02/2025
10b5-1
01/03/2025
Meyer Andrew Hollman
Chief Business Officer
Officer
Sell
-13,334 @ $54.88
($731,785.25)
 82,139 (-13.97%) Direct
12/24/2024
10b5-1
12/27/2024
Campbell David Alan
President and CEO
CEO Director
Sell
-25,000 @ $56.19
($1,404,805.00)
 217,054 (-10.33%) Direct
12/03/2024
10b5-1
12/03/2024
Campbell David Alan
President and CEO
CEO Director
Sell
-15,000 @ $67.00
($1,005,000.00)
 242,054 (-5.84%) Direct
11/25/2024
10b5-1
11/27/2024
Campbell David Alan
President and CEO
CEO Director
Sell
-25,000 @ $51.60
($1,289,878.73)
 257,054 (-8.86%) Direct
10/28/2024
10b5-1
10/30/2024
Campbell David Alan
President and CEO
CEO Director
Sell
-25,000 @ $53.54
($1,338,558.90)
 282,054 (-8.14%) Direct
09/27/2024
10b5-1
09/27/2024
Campbell David Alan
President and CEO
CEO Director
Sell
-25,000 @ $46.31
($1,157,641.43)
 307,054 (-7.53%) Direct
09/27/2024
10b5-1
09/27/2024
Diraimondo Thomas
Chief Scientific Officer
Officer
Sell
-5,000 @ $46.34
($231,716.19)
 97,938 (-4.86%) Direct